Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002327 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | 2023-01-05 | TVTX | Dube Eric M | CEO, Dir | S - Sale | $20.75 | -5,625 | 154.3K | -4% | -$116.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | S | D | 5,625 | $20.75 | 154,288 | D | — | — |